Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/6/2023 | $29.00 | Neutral | UBS |
| 11/13/2023 | $30.00 | Neutral → Buy | BofA Securities |
| 5/9/2023 | $25.00 → $27.00 | Underperform → Neutral | BofA Securities |
| 2/8/2023 | $25.00 → $26.50 | Mkt Perform → Outperform | Keefe Bruyette |
| 1/9/2023 | $24.50 | Neutral → Underperform | Credit Suisse |
| 9/6/2022 | $27.00 | Overweight → Neutral | JP Morgan |
| 8/18/2022 | $25.00 | Neutral → Underperform | BofA Securities |
| 7/18/2022 | $28.00 → $27.00 | Outperform → Mkt Perform | Keefe Bruyette |
8-K - Enact Holdings, Inc. (0001823529) (Filer)
10-K - Enact Holdings, Inc. (0001823529) (Filer)
8-K - Enact Holdings, Inc. (0001823529) (Filer)
RALEIGH, N.C., March 11, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact) today announced that it has appointed H. Elizabeth (Liz) Mitchell as an Independent Director to serve on Enact's Board of Directors, effective March 11, 2025. She has also been appointed as a member of the Audit Committee. In addition, the company announced that Anne G. Waleski has made the decision not to stand for re-election at the 2025 Annual Shareholder Meeting on May 14, 2025. As a result of these actions, Enact's Board will temporarily increase in size from eleven to twelve directors until the company's 2025 Annual Shareholder Meeting. Ms. Mitchell brings deep financial, industry and public
The cost of long-term care services in Wyoming increased year-over-year in certain care settings but decreased in others, remaining on par with national costs, according to the 2024 Cost of Care Survey conducted by Genworth and CareScout. "Genworth and CareScout are committed to helping our customers in Wyoming create person-centered plans for how they want to receive care as they age," said Jamala Arland, President & CEO, Genworth U.S. Life Insurance. "That means integrating a person's values, preferences, and goals into the care they receive. The Cost of Care Survey is a great resource for individuals starting to create a plan, who want to learn more about different care types and see ho
The cost of long-term care services in West Virginia increased year-over-year, exceeding national costs, according to the 2024 Cost of Care Survey conducted by Genworth and CareScout. "Genworth and CareScout are committed to helping our customers in West Virginia create person-centered plans for how they want to receive care as they age," said Jamala Arland, President & CEO, Genworth U.S. Life Insurance. "That means integrating a person's values, preferences, and goals into the care they receive. The Cost of Care Survey is a great resource for individuals starting to create a plan, who want to learn more about different care types and see how costs may grow over time." National 2024 Cost
SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)
SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)
SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)
Strategic Highlights Expanded the CareScout Quality Network to all 50 states, covering over 86% of the aged 65-plus census population in the United States Continued progress on the LTC1 multi-year rate action plan with $40M of gross incremental premium approvals; approximately $31.2B estimated net present value achieved since 2012 from in-force rate actions (IFAs) Executed $51M in share repurchases in the quarter at an average price of $7.32 per share; $186M executed in 2024 at an average price of $6.52 per share; $565M in share repurchases program-to-date through February 14th at an average price of $5.69 per share Repurchased $31M in principal of holding company debt at a discount
GAAP Net Income of $163 million, or $1.05 per diluted shareAdjusted Operating Income of $169 million, or $1.09 per diluted shareReturn on Equity of 13.0% and Adjusted Operating Return on Equity of 13.5%Record Primary insurance in-force of $269 billion, a 2% increase from fourth quarter 2023PMIERs Sufficiency of 167% or $2,052 millionBook Value Per Share of $32.80 and Book Value Per Share excluding AOCI of $34.16Returned over $350 million of capital to shareholders in 2024Announces quarterly cash dividend of $0.185 per common share RALEIGH, N.C., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) today announced its fourth quarter and full-year 2024 results.
RALEIGH, N.C., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact) announced it will issue its fourth quarter earnings release after the market closes on February 4, 2025. Enact will host a conference call to review fourth quarter 2024 financial results on February 5, 2025 at 8:00 a.m. (ET). Enact's earnings release, summary presentation and financial supplement will be available through the company's website, https://ir.enactmi.com/, at the time of their release to the public. Participants interested in joining the call's live question and answer session are required to pre-register by clicking here to obtain a dial-in number and unique PIN. It is recommended to
4 - Enact Holdings, Inc. (0001823529) (Issuer)
4 - Enact Holdings, Inc. (0001823529) (Issuer)
4 - Enact Holdings, Inc. (0001823529) (Issuer)
RALEIGH, N.C., March 11, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact) today announced that it has appointed H. Elizabeth (Liz) Mitchell as an Independent Director to serve on Enact's Board of Directors, effective March 11, 2025. She has also been appointed as a member of the Audit Committee. In addition, the company announced that Anne G. Waleski has made the decision not to stand for re-election at the 2025 Annual Shareholder Meeting on May 14, 2025. As a result of these actions, Enact's Board will temporarily increase in size from eleven to twelve directors until the company's 2025 Annual Shareholder Meeting. Ms. Mitchell brings deep financial, industry and public
UBS initiated coverage of Enact Holdings with a rating of Neutral and set a new price target of $29.00
BofA Securities upgraded Enact Holdings from Neutral to Buy and set a new price target of $30.00
BofA Securities upgraded Enact Holdings from Underperform to Neutral and set a new price target of $27.00 from $25.00 previously